Masquelin, Axel H.
Cheney, Nicholas
Kinsey, C. Matthew
Bates, Jason H. T. https://orcid.org/0000-0002-6062-6377
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (T32 HL076122)
National Heart, Lung, and Blood Institute (K23 HL133476)
National Heart, Lung, and Blood Institute (U01 HL139466)
Article History
Accepted: 30 December 2020
First Online: 27 January 2021
Compliance with ethical standards
:
: AHM is a consultant and equity holder for Predictive Wear LLC. JHTB consults for Johnson & Johnson on approaches to treating lung cancer. CMK is a consultant for Olympus America, Johnson and Johnson, and consultant and equity holder for Quantitative Imaging Solutions. He serves on the steering committee for Nuvaira and the Scientific Advisory Board for Gala Therapeutics. He reports grants from the NIH, the DECAMP Consortium (funded by Johnson and Johnson through Boston University), and a patent pending for “Bates JHT and Kinsey CM. Methods for Computational Modeling to Guide Intratumoral Therapy.”